Siblings Exim Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 26-12-2024
- Revenue 4405.37%
(FY 2022)
- Profit 123.58%
(FY 2022)
- Ebitda -37.56%
(FY 2022)
- Net Worth 33.43%
(FY 2022)
- Total Assets 270.63%
(FY 2022)
About Siblings Exim
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Papia Datta, Ritika Dutta, and Rituparna Bhattacharya serve as directors at the Company.
- CIN/LLPIN
U74999WB2019PTC231506
- Company No.
231506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Siblings Exim Private Limited offer?
Siblings Exim Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Honey & Sweeteners, Cooking Spices and Masala, Whole Spices, Seeds and Plant Saplings, Edible Seeds, Oil Seeds, Organic Food Grains & Vegetables, Organic Sugar, Ayurvedic Powder and Medicinal Herbs.
Who are the key members and board of directors at Siblings Exim?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Papia Datta  | Director | 19-Apr-2019 | Current |
| Ritika Dutta | Director | 19-Apr-2019 | Current |
| Rituparna Bhattacharya | Director | 10-Jan-2022 | Current |
Financial Performance of Siblings Exim.
Siblings Exim Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4405.37% increase. The company also saw a substantial improvement in profitability, with a 123.58% increase in profit. The company's net worth Soared by an impressive increase of 33.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siblings Exim?
In 2021, Siblings Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Sep 2024 | ₹1.00 M | Open |
How Many Employees Work at Siblings Exim?
Unlock and access historical data on people associated with Siblings Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siblings Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siblings Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
